The effect of ageing on the pharmacokinetics of dihydrocodeine

Although poor renal function reduces clearance of dihydrocodeine in man, and renal impairment occurs with ageing, no significant differences occurred in the handling of single doses of dihydrocodeine between elderly patients and young, normal subjects. After multiple dosing, the maximum concentratio...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of clinical pharmacology 1989-01, Vol.37 (4), p.375-379
Hauptverfasser: DAVIES, K. N, CASTLEDEN, C. M, MCBURNEY, A, JAGGER, C
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 379
container_issue 4
container_start_page 375
container_title European journal of clinical pharmacology
container_volume 37
creator DAVIES, K. N
CASTLEDEN, C. M
MCBURNEY, A
JAGGER, C
description Although poor renal function reduces clearance of dihydrocodeine in man, and renal impairment occurs with ageing, no significant differences occurred in the handling of single doses of dihydrocodeine between elderly patients and young, normal subjects. After multiple dosing, the maximum concentration was significantly different between the groups, being higher in the elderly. The increase in the area under the curve in the elderly was 25% greater than in the young on chronic therapy. This difference was not statistically significant, but was likely to be of clinical significance. The elderly patients' mean creatinine clearance (61.8 ml per min) was significantly lower than that in the young (137 ml per min), and there was a significant correlation between the half-life at single dosing and the blood urea concentration. Variability in all measurements was marked in both groups, and hence no clear guidelines can be given on therapeutic dosing. The small initial dose with alterations thereafter depending on clinical effect is the best advice.
doi_str_mv 10.1007/BF00558503
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79390264</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>79390264</sourcerecordid><originalsourceid>FETCH-LOGICAL-c311t-1926b4860490d6a54f91c39c00af36829b593dd3e2bd7f98a9977fafed1eeea93</originalsourceid><addsrcrecordid>eNpF0MFLwzAUBvAgypzTi3ehB_EgVF-aNu27CDqcCgMv81zS5GWrds1MusP-eztW5unB-358h4-xaw4PHCB_fJkBZFmRgThhY56KJOaQ8lM2BhA8lpjDObsI4RuAZwhixEZJhgVKHLOnxYoispZ0FzkbqSXV7TJybdT1_81K-bXS7qduqat12AtTr3bGO-1ML-mSnVnVBLoa7oR9zV4X0_d4_vn2MX2ex1pw3sUcE1mlhYQUwUiVpRa5FqgBlBWySLDKUBgjKKlMbrFQiHlulSXDiUihmLC7Q-_Gu98tha5c10FT06iW3DaUOQqERKY9vD9A7V0Inmy58fVa-V3JodyPVf6P1eOboXVbrckc6bBOn98OuQpaNdarVtfhyKQsgBeZ-APQ0G_b</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>79390264</pqid></control><display><type>article</type><title>The effect of ageing on the pharmacokinetics of dihydrocodeine</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>DAVIES, K. N ; CASTLEDEN, C. M ; MCBURNEY, A ; JAGGER, C</creator><creatorcontrib>DAVIES, K. N ; CASTLEDEN, C. M ; MCBURNEY, A ; JAGGER, C</creatorcontrib><description>Although poor renal function reduces clearance of dihydrocodeine in man, and renal impairment occurs with ageing, no significant differences occurred in the handling of single doses of dihydrocodeine between elderly patients and young, normal subjects. After multiple dosing, the maximum concentration was significantly different between the groups, being higher in the elderly. The increase in the area under the curve in the elderly was 25% greater than in the young on chronic therapy. This difference was not statistically significant, but was likely to be of clinical significance. The elderly patients' mean creatinine clearance (61.8 ml per min) was significantly lower than that in the young (137 ml per min), and there was a significant correlation between the half-life at single dosing and the blood urea concentration. Variability in all measurements was marked in both groups, and hence no clear guidelines can be given on therapeutic dosing. The small initial dose with alterations thereafter depending on clinical effect is the best advice.</description><identifier>ISSN: 0031-6970</identifier><identifier>EISSN: 1432-1041</identifier><identifier>DOI: 10.1007/BF00558503</identifier><identifier>PMID: 2598969</identifier><language>eng</language><publisher>Heidelberg: Springer</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Aging - blood ; Aging - metabolism ; Aging - physiology ; Analgesics ; Biological and medical sciences ; Codeine - administration &amp; dosage ; Codeine - analogs &amp; derivatives ; Codeine - blood ; Codeine - pharmacokinetics ; Female ; Humans ; Kidney - physiology ; Male ; Medical sciences ; Neuropharmacology ; Pharmacology. Drug treatments</subject><ispartof>European journal of clinical pharmacology, 1989-01, Vol.37 (4), p.375-379</ispartof><rights>1990 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c311t-1926b4860490d6a54f91c39c00af36829b593dd3e2bd7f98a9977fafed1eeea93</citedby><cites>FETCH-LOGICAL-c311t-1926b4860490d6a54f91c39c00af36829b593dd3e2bd7f98a9977fafed1eeea93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=6680185$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2598969$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>DAVIES, K. N</creatorcontrib><creatorcontrib>CASTLEDEN, C. M</creatorcontrib><creatorcontrib>MCBURNEY, A</creatorcontrib><creatorcontrib>JAGGER, C</creatorcontrib><title>The effect of ageing on the pharmacokinetics of dihydrocodeine</title><title>European journal of clinical pharmacology</title><addtitle>Eur J Clin Pharmacol</addtitle><description>Although poor renal function reduces clearance of dihydrocodeine in man, and renal impairment occurs with ageing, no significant differences occurred in the handling of single doses of dihydrocodeine between elderly patients and young, normal subjects. After multiple dosing, the maximum concentration was significantly different between the groups, being higher in the elderly. The increase in the area under the curve in the elderly was 25% greater than in the young on chronic therapy. This difference was not statistically significant, but was likely to be of clinical significance. The elderly patients' mean creatinine clearance (61.8 ml per min) was significantly lower than that in the young (137 ml per min), and there was a significant correlation between the half-life at single dosing and the blood urea concentration. Variability in all measurements was marked in both groups, and hence no clear guidelines can be given on therapeutic dosing. The small initial dose with alterations thereafter depending on clinical effect is the best advice.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Aging - blood</subject><subject>Aging - metabolism</subject><subject>Aging - physiology</subject><subject>Analgesics</subject><subject>Biological and medical sciences</subject><subject>Codeine - administration &amp; dosage</subject><subject>Codeine - analogs &amp; derivatives</subject><subject>Codeine - blood</subject><subject>Codeine - pharmacokinetics</subject><subject>Female</subject><subject>Humans</subject><subject>Kidney - physiology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Neuropharmacology</subject><subject>Pharmacology. Drug treatments</subject><issn>0031-6970</issn><issn>1432-1041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1989</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpF0MFLwzAUBvAgypzTi3ehB_EgVF-aNu27CDqcCgMv81zS5GWrds1MusP-eztW5unB-358h4-xaw4PHCB_fJkBZFmRgThhY56KJOaQ8lM2BhA8lpjDObsI4RuAZwhixEZJhgVKHLOnxYoispZ0FzkbqSXV7TJybdT1_81K-bXS7qduqat12AtTr3bGO-1ML-mSnVnVBLoa7oR9zV4X0_d4_vn2MX2ex1pw3sUcE1mlhYQUwUiVpRa5FqgBlBWySLDKUBgjKKlMbrFQiHlulSXDiUihmLC7Q-_Gu98tha5c10FT06iW3DaUOQqERKY9vD9A7V0Inmy58fVa-V3JodyPVf6P1eOboXVbrckc6bBOn98OuQpaNdarVtfhyKQsgBeZ-APQ0G_b</recordid><startdate>19890101</startdate><enddate>19890101</enddate><creator>DAVIES, K. N</creator><creator>CASTLEDEN, C. M</creator><creator>MCBURNEY, A</creator><creator>JAGGER, C</creator><general>Springer</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19890101</creationdate><title>The effect of ageing on the pharmacokinetics of dihydrocodeine</title><author>DAVIES, K. N ; CASTLEDEN, C. M ; MCBURNEY, A ; JAGGER, C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c311t-1926b4860490d6a54f91c39c00af36829b593dd3e2bd7f98a9977fafed1eeea93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1989</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Aging - blood</topic><topic>Aging - metabolism</topic><topic>Aging - physiology</topic><topic>Analgesics</topic><topic>Biological and medical sciences</topic><topic>Codeine - administration &amp; dosage</topic><topic>Codeine - analogs &amp; derivatives</topic><topic>Codeine - blood</topic><topic>Codeine - pharmacokinetics</topic><topic>Female</topic><topic>Humans</topic><topic>Kidney - physiology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Neuropharmacology</topic><topic>Pharmacology. Drug treatments</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>DAVIES, K. N</creatorcontrib><creatorcontrib>CASTLEDEN, C. M</creatorcontrib><creatorcontrib>MCBURNEY, A</creatorcontrib><creatorcontrib>JAGGER, C</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of clinical pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>DAVIES, K. N</au><au>CASTLEDEN, C. M</au><au>MCBURNEY, A</au><au>JAGGER, C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The effect of ageing on the pharmacokinetics of dihydrocodeine</atitle><jtitle>European journal of clinical pharmacology</jtitle><addtitle>Eur J Clin Pharmacol</addtitle><date>1989-01-01</date><risdate>1989</risdate><volume>37</volume><issue>4</issue><spage>375</spage><epage>379</epage><pages>375-379</pages><issn>0031-6970</issn><eissn>1432-1041</eissn><abstract>Although poor renal function reduces clearance of dihydrocodeine in man, and renal impairment occurs with ageing, no significant differences occurred in the handling of single doses of dihydrocodeine between elderly patients and young, normal subjects. After multiple dosing, the maximum concentration was significantly different between the groups, being higher in the elderly. The increase in the area under the curve in the elderly was 25% greater than in the young on chronic therapy. This difference was not statistically significant, but was likely to be of clinical significance. The elderly patients' mean creatinine clearance (61.8 ml per min) was significantly lower than that in the young (137 ml per min), and there was a significant correlation between the half-life at single dosing and the blood urea concentration. Variability in all measurements was marked in both groups, and hence no clear guidelines can be given on therapeutic dosing. The small initial dose with alterations thereafter depending on clinical effect is the best advice.</abstract><cop>Heidelberg</cop><cop>Berlin</cop><pub>Springer</pub><pmid>2598969</pmid><doi>10.1007/BF00558503</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0031-6970
ispartof European journal of clinical pharmacology, 1989-01, Vol.37 (4), p.375-379
issn 0031-6970
1432-1041
language eng
recordid cdi_proquest_miscellaneous_79390264
source MEDLINE; SpringerLink Journals - AutoHoldings
subjects Adult
Aged
Aged, 80 and over
Aging - blood
Aging - metabolism
Aging - physiology
Analgesics
Biological and medical sciences
Codeine - administration & dosage
Codeine - analogs & derivatives
Codeine - blood
Codeine - pharmacokinetics
Female
Humans
Kidney - physiology
Male
Medical sciences
Neuropharmacology
Pharmacology. Drug treatments
title The effect of ageing on the pharmacokinetics of dihydrocodeine
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T05%3A32%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20effect%20of%20ageing%20on%20the%20pharmacokinetics%20of%20dihydrocodeine&rft.jtitle=European%20journal%20of%20clinical%20pharmacology&rft.au=DAVIES,%20K.%20N&rft.date=1989-01-01&rft.volume=37&rft.issue=4&rft.spage=375&rft.epage=379&rft.pages=375-379&rft.issn=0031-6970&rft.eissn=1432-1041&rft_id=info:doi/10.1007/BF00558503&rft_dat=%3Cproquest_cross%3E79390264%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=79390264&rft_id=info:pmid/2598969&rfr_iscdi=true